Skip to main content
. 2021 Aug 31;10(18):6456–6467. doi: 10.1002/cam4.4158

TABLE 1.

Characteristics of mammography cohort

All patients

N = 198,278

N (%) or Mean (SD)
Age at screening (years) 54.30 (11.04)
Age at screening (categories)
40–49 80,416 (40.6%)
50–59 57,717 (29.1%)
60–69 38,641 (19.5%)
70+ 21,504 (10.8%)
Prior biopsies
0 176,549 (89.0%)
1 17,168 (8.7%)
2 or more 4561 (2.3%)
Atypical hyperplasia 1734 (0.9%)
Age at menarche
<12 31,802 (16.0%)
12–13 99,978 (50.4%)
14+ 47,558 (24.0%)
Missing 18,940 (9.6%)
Age at first live birth
No births 42,217 (21.3%)
Under 20 20,123 (10.1%)
20–24 36,625 (18.5%)
25–29 41,524 (20.9%)
30 or older 46,077 (23.2%)
Missing 11,712 (5.9%)
Number of relatives with breast cancer
0 173,075 (87.3%)
1 22,969 (11.6%)
2+ 2234 (1.1%)
Race/ethnicity
White 146,159 (73.7%)
Black/African American 29,822 (15.0%)
Hispanic/Latino 6585 (3.3%)
Asian/Pacific Islander 9371 (4.7%)
Other/unknown 6341 (3.2%)
BMI
<25 76,035 (38.3%)
25–29.9 49,461 (24.9%)
30+ 49,484 (25.0%)
Missing 23,298 (11.8%)
Postmenopausal 115,405 (58.2%)
Number of live births
0 42,217 (21.3%)
1 41,269 (20.8%)
2 52,116 (26.3%)
3 28,054 (14.1%)
4+ 16,032 (8.1%)
Missing 18,590 (9.4%)
BI‐RADS breast density
BI‐RADS A 15,348 (7.7%)
BI‐RADS B 76,196 (38.4%)
BI‐RADS C 87,459 (44.1%)
BI‐RADS D 15,740 (7.9%)
Unknown 3535 (1.8%)
Site
MGH 79,671 (40.2%)
NWH 52,331 (26.4%)
Penn 66,276 (33.4%)
Breast cancers
DCIS 1158 (22.4%)
Total invasive 4002 (77.6%)
Invasive ER/PR+HER2− 3077 (76.9%)
Invasive triple negative 300 (7.5%)
Invasive ER/PR+HER2+ 342 (8.5%)
Invasive ER/PR−HER2+ 126 (3.2%)
Invasive missing 157 (3.9%)

Abbreviations: ER/PR, estrogen receptor/progesterone receptor; HER2, human epidermal growth factor receptor 2; MGH, Massachusetts General Hospital; NWH, Newton‐Wellesley Hospital.